PRMT1 and colorectal adenocarcinoma: Similarly, as shown in Figure 5C,D, colorectal adenocarcinoma patients with rectal tumors (50 for DFS and 62 for OS) and lower levels of circ-PRMT1 had significantly higher probabilities of both DFS (p = 0.007) and OS (p < 0.001).